unknown
Stage
About
Immuto Scientific develops an AI-enabled platform for characterizing disease-specific surface protein conformations to identify novel targets for precision therapeutics, primarily focused on cancer.
Explore Immuto Scientific's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.